NHP National Healthcare Properties, Inc.
Real Estate Investment Trusts · Nasdaq · SEC CIK 1561032 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q3*2026-09-30 | 2026Q2*2026-06-30 | 2026Q1*2026-03-31 | 2025Q4*2025-12-31 | 2025Q3*2025-09-30 | 2025Q2*2025-06-30 | 2025Q1*2025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $103.06M | $87.53M | $86.28M | $84.48M | $86.03M | $85.33M | $86.44M | $87.74M |
| Gross profit | $33.49M | $33.41M | $33.37M | $31.46M | $32.18M | $31.15M | $28.59M | $33.15M |
| SG&A expense | $7.81M | $6.60M | $5.47M | $8.55M | $5.67M | $5.08M | $4.90M | $5.81M |
| Operating income | $31.81M | $5.09M | $10.11M | -$6.58M | $2.38M | -$5.52M | $13.02M | -$1.05M |
| Interest expense | $12.16M | $12.72M | $14.67M | $15.86M | $15.06M | $15.84M | $14.53M | $17.30M |
| Pretax income | $20.14M | -$5.34M | -$4.20M | -$22.70M | -$12.47M | -$20.83M | -$1.52M | -$16.90M |
| Income tax | -$97,000 | $47,000 | $77,000 | $101,000 | $66,000 | $0 | -$6,000 | $127,000 |
| Net income | $20.18M | -$5.36M | -$4.31M | -$22.70M | -$12.55M | -$20.80M | -$1.57M | -$16.99M |
| EBITDA | $56.23M | $22.90M | $27.84M | $11.41M | $20.40M | $13.02M | $36.73M | $19.63M |
| EPS (basic) | 0.24 | -0.13 | -0.27 | — | -0.56 | -0.85 | -0.18 | — |
| EPS (diluted) | 0.24 | -0.13 | -0.27 | — | -0.56 | -0.85 | -0.18 | — |
| Dividends declared per share | 0.07 | — | — | — | — | — | — | 0.64 |
| Weighted avg. shares (diluted) | — | 61.60M | 28.34M | — | 28.30M | 28.30M | 28.30M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $125.07M | $245.69M | $52.81M | $57.62M | $102.54M | $103.17M | $126.41M | $74.09M |
| Intangibles | $235.25M | $250.44M | $246.54M | $246.54M | $248.06M | $249.94M | $256.44M | $55.37M |
| Total assets | $1.91B | $1.98B | $1.70B | $1.71B | $1.74B | $1.76B | $1.83B | $1.95B |
| Total liabilities | $993.74M | $919.05M | $1.10B | $1.11B | $1.11B | $1.11B | $1.15B | $1.26B |
| Shareholders' equity | $918.18M | $1.05B | $592.16M | $600.06M | $627.22M | $647.03M | $674.58M | $684.56M |
| Shares outstanding | — | — | 28.41M | 28.43M | 28.43M | 28.45M | 28.30M | 28.30M |
| Cash flow statement | ||||||||
| Operating cash flow | $15.73M | $21.61M | $9.01M | $9.96M | $10.17M | $8.05M | -$21.23M | $6.45M |
| Investing cash flow | -$80.65M | -$103.38M | -$5.42M | -$3.33M | -$3.01M | -$1.90M | $78.04M | $5.41M |
| Financing cash flow | -$93.42M | $277.55M | -$5.45M | -$712,000 | -$7.80M | -$29.39M | -$4.50M | -$22.68M |
| Depreciation & amortization | $24.42M | $17.81M | $17.74M | $17.99M | $18.03M | $18.54M | $23.71M | $20.68M |
| Stock-based compensation | $2.10M | $1.60M | $612,000 | $1.86M | $1.30M | $600,000 | $0 | $0 |
Free plan shows the latest 8 periods; Pro shows all 56 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.